DAWN G. HOLCOMBE, FACMPE, MBA
33 Woodmar Circle
South Windsor, CT 06074
860-305-4510, dawnholcombe@aol.com
Now a private consultant to providers, payers and pharma, Dawn Holcombe’s over thirty years in healthcare have included executive, strategic, financial, and marketing positions in academic and private health systems as well as physician practices. She is a past President of the national Administrators in Oncology Hematology Assembly (AOHA) of the Medical Group Management Association (MGMA), and Editor in Chief for "Oncology Practice Management". Mrs. Holcombe also serves as an Editorial Board Advisor for national monthly publications including “Value Based Cancer Care”, and on the Boards of the national Community Oncology Alliance (COA) and the Hematology/Oncology Managers of New York (HOMny). She was also recently Senior Vice President for Payer Relations and Quality Programs for both Supportive Oncology Services and its large network of affiliated oncology practices and the Cancer Clinics of Excellence, and Executive Director for the Oncology Network of Connecticut, LLC for over a decade (which was recently disbanded in favor of a single CT oncology voice, the Connecticut Oncology Association).
Dawn also serves as the Executive Director for the Connecicut Oncology Association, and has held other state and national positions in MGMA as well as several healthcare professional organizations. She is a Fellow in the American College of Medical Practice Executives (AMCPE), and earned her MBA at the University of Michigan. Her fellowship paper for ACMPE was entitled: “The Evolution of Community Oncology Care and its Threatened Extinction through Federal and Private Payment Reform.”
DGH Consulting provides consulting and speaking services that concentrate on strategic planning and payer/physician relationships; building quality and value programs; trends in Pay for performance, disease management and oncology pharmaceutical management; as well as local and national Medicare and managed care concerns.
Publications
§ “Accountable Care Organizations – Fervor Fading Fast” – Value Based Cancer Care Summer 2011
§ “Oncology Clinical Guidelines: NCCN and Proventys” – Value Based Care Care Summer 2011
§ “Oncology Management Programs for Payers and Physicians: Evaluating Current Models and Diagnosing Successful Strategies for Payers and Physicians”, by Dawn Holcombe, special joint issue of American Journal of Managed Care and Journal of Oncology Practice (ASCO), May 2011
§ “Clinical Pathways Programs: Confusing Choices for Payers and Physicians: Part 2: Promising Options”, by Dawn Holcombe, Journal of Multidisciplinary Cancer Care, October 2010, Pages 19 - 20.
§ “Clinical Pathways Programs: Confusing Choices for Payers and Physicians: Part 1: Selecting the Appropriate Pathways Program”, by Dawn Holcombe, Journal of Multidisciplinary Cancer Care, August 2010, Pages 10-11.
§ “Welcome to the Vortex – Negotiating and Building Relationships with Your Payers” by Dawn Holcombe, Oncology Issues, published by the Association of Community Cancer Centers, January/February 2010, Pages 42 – 46.
§ “How to Avoid Being Left Behind in a Changing Market”, by Dawn Holcombe, Hematology News and Issues, October 2009, Page 38 - 40.
§ “Federal Policy Oversteps Bounds Into Medical Decision-making for Oral vs IV Treatment”, by Dawn Holcombe, Journal of Multidisciplinary Cancer Care, September/October 2009, Vol. 1, No. 5, Page 1, 18-19.
§ “Bigger than Y2K, and inevitable – ICD-CM-10”, by Dawn Holcombe, Hematology News and Issues, October 2008, Page 43.
§ “Track today, for you will be asked tomorrow, by Dawn Holcombe, Hematology & Oncology News & Issues, August/September 2008, Pages 30 – 34.
§ “Strategic Planning & Retreats for Practices: What you need to know, want to know, and may be afraid to find out”, by Dawn Holcombe, Oncology Issues, published by the Association of Community Cancer Centers, September/October 2008, Pages 26-31.
§ “Pursuing Quality Care in 2008”, by Dawn Holcombe, Community Oncology, published by Elesevier Press, Volume 5, Number 4, Pages 188-190.
§ “Payers and Providers: A love match?”, by Dawn Holcombe, Community Oncology, published by Elesevier Press, Volume 5, Number 4, Pages 197-199.
§ “Quality and oncology: who’s on first?”, by Dawn Holcombe, Community Oncology, published by Elesevier Press, Volume 5, Number 3, Pages 125- 126.
§ “Opinion leaders on quality in cancer: views from the field”, by Dawn Holcombe, Community Oncology, published by Elesevier Press, Volume 5, Number 3, Pages 153 - 158.
§ Guest Editor, “Focus on Quality Care Issue”, Community Oncology, published by Elesevier Press, Volume 5, Number 3.
§ “Pay for Performance & Oncology Practices, At the Crossroads, What Your Oncology Practice Can Do Today”, By Dawn Holcombe, Oncology Issues , published by the Association of Community Cancer Centers (ACCC), March/April 2007 issue, Pages 26 – 30.
§ “Is your practice ready for an uncertain future? The questions you should be asking your staff” By Dawn Holcombe , Community Oncology, VOLUME 3, NUMBER 3 (March 2006)
§ “The High Costs of low-priced cancer drugs”, Dangerous Doses: How Counterfeiters Are Contaminating America’s Drug Supply, by Katherine Eban, Harcourt Press, Reviewed by Dawn Holcombe in Community Oncology, VOLUME 2, NUMBER 5 (September/October 2005) http://communityoncology.net/journal/articles/0205408.pdf
§ “Is Oncology Compatible with Specialty Pharmacy?” By Dawn Holcombe, Community Oncology, VOLUME 2, NUMBER 2 (March/April 2005) http://communityoncology.net/journal/articles/0202173.pdf
§ “The Evolution of Community Oncology Care and its Threatened Extinction through Federal and Private Payment Reform.” Fellowship Paper, American College of Medical Practice Executives, 2003
“Building Revenue From Purchased Physician Practices”, Co-Authored by Dawn Holcombe and William G. Galvagni, The Alliance Report, The Alliance for Healthcare Strategy and Marketing, May/June 1996
Selected Presentations to: national conferences (National Association Managed Care Physicians, Institute of Health and Productivy Management, Association for Community Cancer Centers (ACCC) Spring and Fall Conferences, First Annual conference for Association for Value0Based Cancer Care, Oncology World Congress, Medical Group Management Association (MGMA), Community Oncology Congress, Association of Managed Care Pharmacists, AOHA Annual Conference (Administrators in Oncology Hematology Assembly – affiliate of the MGMA), Oncology Economics Summit, 4th Annual National Pay for Performance Summit), CBI’s Effective Oncology Benefit Management, CBI’s Sixth Annual Specialty Pharmacy Conference, state conferences for dozens of state oncology associations, and numerous other regional or practice meetings.
§ “Oncology Overview and Issues for Payers”
§ “Oncology Overview for Employers”
§ “Oncology Community Practice: Then and Now, Practice and Pressures”
§ “Oncology Management: Public and Private, Physician, Payer and Third Party”
§ “2011 Oncology Issues and Trends”
§ “2010 – 2011 Oncology Trend Report” – for Genentech
§ “Patient Navigators – Trends and Issues”
§ “Oncology Management Trends: Who, How, Why, and What you need to ask”
§ New Realities of Oncology Contracting for Payers and Physicians”
§ “2010 Oncology Issues and Trends”
§ “Oncology and Specialty Pharmacy: The Issues, Challenges and Future”
§ “2009 Oncology Issues and Trends”
§ “Who’s Managing Oncology: A Growing Question for Payers, Provider (and others)
§ “Comparative Effectiveness and Oncology” – Chaired and Presented in a 4 Hour Workshop
§ “More Stormy Weather Ahead: What to Expect re the OIG Work Plan, RACs and the Red Flag rules”
§ “Oncology and Specialty Pharmacy: trends and issues for Oncology and Payers”
§ Panel Discussion and Moderator “Pursuing quality care in 2008”
§ Panel Discussion and Moderator “Payers and Providers: A love match?”
§ “Proving Value in Oncology: The Visible and Invisible Issues”
§ “Understanding Oncology”
§ “Pay for Performance and Oncology: Opportunities and Issues”
§ “Buy and Bill or Specialty Pharmacy: Who Decides?”
§ “Canadian Drugs – What the Marketing Brochures don’t tell you”
§ “The Evolution of Community Oncology”
§ “What is Community Oncology”
§ “Oncology in the 21st Century: Proving Value”
§ “Pay for Performance, Disease Management and Quality: Survival Skills for Oncology for the Next Two Years”
§ “Oncology Payer Updates – Trends in Quality and Pay for Performance”
§ “Pay for Performance - The Inevitable Future”
§ “Future Strategies of Oncology Management in Specialty Pharmacy”
§ “CMS CAP From Provider Perspective”
§ “Oncology – Is it compatible with Specialty Pharmacy”
§ “Oncology Reimbursement and Legislative Policy Updates”
§ “Optimizing Patient Care and Payer Relationships in a Changing Environment”
§ “The Basics of Marketing for Oncology”
§ “In a New World of Pay for Quality, the Not so Obvious Oncology Marketing Solutions”
Dawn Holcombe, FACMPE, MBA
Career Review
Opinion Leader in Oncology
- National thought leader on federal and local oncology policy and practice within oncology administration community, recognized as well as in other industries such as managed care and specialty pharmacy,.
- Served as one of five national advisors regarding oncology development on PROMETHEUS project (www.prometheuspayment.org) (headed by Francois DeBrantes, National Director Bridges to Excellence and Alice Gosfield, Atty)
- Sought for speaking engagements, articles, and interviews with several national Medicare, oncology, and biotechnology publications.
- Frequently sought for advisory boards covering topics that include payer relations, pay for performance, oncology reimbursement reform, and practice networking and operations
- 4 year Member of national 18 person Comprehensive Oncology Coding Task Force – provided guidance and white papers to Congressional and Administration Leadership re: oncology payment reform and operations issues
- Nominated in 2007 and 2008 as candidate for Medicare Payment Advisory Commission position, with references and recommendations from physicians, payers, pharma, private industry, and policy leaders
Connecticut/New England Leader in Healthcare
- For 2 years, active in analysis and marketing leadership in Connecticut Hospital Association and Ct hospitals
- For next 5 years, active in analysis and new business development for western MA/CT region, requiring detailed understanding of politics and market forces across the region
- For next 5 years, active in academic institutions in CT region, from physician practice perspective, but crossing Hartford Hospital, Saint Frances and University of CT domains
- For next year, active in private practice and hospital market in southern CT, crossing Saint Raphael and Yale market domains
- For 15 years, dominant in policy and advocacy issues from oncology practice perspective, connecting state and regional issues with national market
- Represents all oncologists in the state of CT in discussions regarding health plan, federal and Medicaid policy
- Point of primary contact with national and local payers for oncology policy and issues
- Member of the Connecticut Cancer Partnership, a broad and diverse coalition of individuals and organizations representing stakeholders in Connecticut's cancer community.
Federal and State Legislative Impact
- Key resource for last ten years on oncology issues for each member of the Congressional House and Senate from Connecticut in Washington, the State Director for Medicaid, as well as the regional Medical Directors for all major health plans serving Connecticut residents.
- Member of the CT Cancer Partnership
- Key oncology resource for Connecticut State Medical Society
- Served as primary educational resource for CT oncology practices and physicians regarding information on public and private payment trends and issues, as well as federal oncology policy changes, tracking and interpreting all relevant Medicare rules and legislation, as well as OIG, GAO and MedPac reports and testimonies
- 4 year Member of national 18 person Comprehensive Oncology Coding Task Force – provided guidance and white papers to Congressional and Administration Leadership re: oncology payment reform and operations issues
Pay for Performance/Quality Issues and Payer Relations
- Created national oncology benchmarking and value-based performance reporting program for which payers, practices and quality organizations are now in active discussions.
- Nationally sought as speaker for state oncology associations, public and private practice groups on trends in pay for performance and quality issues as well as payer trends (both public and private)
- Frequently oncology practice representative at key national conferences and forums focused on pay for performance and quality management trends and advances
Leadership
- Was a respected leader of staffs ranging in size from solo office, 2-5, 20-25, and 55+ in settings encompassing health systems, private consulting, private and academic orthopedic surgery practices, and single specialty oncology network of private practices
- Treated support staff with courtesy and respect, receiving same in return, encouraged professional growth and expansion of responsibilities/opportunities where appropriate
- Leadership through election to 4 year term of Executive Board of the major professional oncology administrators, including Presidency in third year
- Consistent history of decades of key leadership positions in local, state, regional and national organizations, covering a variety of specializations (oncology, healthcare marketing, medical management, general marketing, and civic/non-profit organizations)
- Represented state of CT in key national American Society of Clinical Oncologists (ASCO) Clinical Practice Committee for 10 years through present, as well as Associations for Community Cancer Centers (ACCC) annual President Invitational Retreats
- Achieved highest level of professional certification, Fellow Status in the American College of Medical Practice Executives
- Invited to serve on Medical Group Management Association select national committees on Finance and Audit, as well as Professional Papers Committee that reviews potential new Fellows professional submissions for grading
Physician Practice Networking
- Led network of 9 independent practices for over 10 years (unique in nation)
- Addressed issues including: practice efficiencies, effective contracting, legislative policy and advocacy
- Established national reputation and key national contacts for network related to clinical and contracting issues, drug purchasing and management, and legislative advocacy
- Active member of ad hoc national state oncology association leadership network, both participating in and coordinating bi-annual networking meetings
- Board member of national state oncology association leadership network, Hematology Oncology Leadership Network (HOLN), active on contracting and negotiations committee
- Active contributor on MGMA Administrators in Oncology Hematology Assembly (AOHA) list serve and others focused in oncology for both payers and providers
|
|